Pregabalin is an anticonvulsant drug used for the treatment of epilepsy, neuropathic pain, fibromyalgia, and generalized anxiety disorder. Its mode of action involves decrease in pain signals sent by the damaged nerves in the body.
Increase in geriatric population suffering from neuropathic diabetes and rise in prevalence of diabetes, HIV, cancer, epilepsy, fibromyalgia, and other such disorders are expected to drive the Pregabalin market.
Increase in geriatric population suffering from neuropathic diabetes and rise in prevalence of diabetes, HIV, cancer, epilepsy, fibromyalgia, and other such disorders are expected to drive the Pregabalin market.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Pregabalin Market Size Growth Rate by Type (2019-2025)
1.3.2 Epilepsy
1.3.3 Neuropathic Pain
1.3.4 Fibromyalgia
1.3.5 Generalized Anxiety Disorder
1.4 Market Segment by Application
1.4.1 Global Pregabalin Market Share by Application (2019-2025)
1.4.2 Research Institutes
1.4.3 Pharmaceutical Companies
1.4.4 Others (Hospitals and Clinics)
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pregabalin Market Size
2.1.1 Global Pregabalin Revenue 2014-2025
2.1.2 Global Pregabalin Sales 2014-2025
2.2 Pregabalin Growth Rate by Regions
2.2.1 Global Pregabalin Sales by Regions 2014-2019
2.2.2 Global Pregabalin Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Pregabalin Sales by Manufacturers
3.1.1 Pregabalin Sales by Manufacturers 2014-2019
3.1.2 Pregabalin Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Pregabalin Revenue by Manufacturers (2014-2019)
3.2.2 Pregabalin Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Pregabalin Market Concentration Ratio (CR5 and HHI)
3.3 Pregabalin Price by Manufacturers
3.4 Key Manufacturers Pregabalin Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Pregabalin Market
3.6 Key Manufacturers Pregabalin Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Epilepsy Sales and Revenue (2014-2019)
4.1.2 Neuropathic Pain Sales and Revenue (2014-2019)
4.1.3 Fibromyalgia Sales and Revenue (2014-2019)
4.1.4 Generalized Anxiety Disorder Sales and Revenue (2014-2019)
4.2 Global Pregabalin Sales Market Share by Type
4.3 Global Pregabalin Revenue Market Share by Type
4.4 Pregabalin Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Pregabalin Sales by Application
6 United States
6.1 United States Pregabalin Breakdown Data by Company
6.2 United States Pregabalin Breakdown Data by Type
6.3 United States Pregabalin Breakdown Data by Application
7 European Union
7.1 European Union Pregabalin Breakdown Data by Company
7.2 European Union Pregabalin Breakdown Data by Type
7.3 European Union Pregabalin Breakdown Data by Application
8 China
8.1 China Pregabalin Breakdown Data by Company
8.2 China Pregabalin Breakdown Data by Type
8.3 China Pregabalin Breakdown Data by Application
9 Rest of World
9.1 Rest of World Pregabalin Breakdown Data by Company
9.2 Rest of World Pregabalin Breakdown Data by Type
9.3 Rest of World Pregabalin Breakdown Data by Application
9.4 Rest of World Pregabalin Breakdown Data by Countries
9.4.1 Rest of World Pregabalin Sales by Countries
9.4.2 Rest of World Pregabalin Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Pfizer Inc.
10.1.1 Pfizer Inc. Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Pregabalin
10.1.4 Pregabalin Product Introduction
10.1.5 Pfizer Inc. Recent Development
10.2 Torrent Pharmaceuticals Ltd.
10.2.1 Torrent Pharmaceuticals Ltd. Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Pregabalin
10.2.4 Pregabalin Product Introduction
10.2.5 Torrent Pharmaceuticals Ltd. Recent Development
10.3 Lupin Limited
10.3.1 Lupin Limited Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Pregabalin
10.3.4 Pregabalin Product Introduction
10.3.5 Lupin Limited Recent Development
10.4 Zydus Cadila Healthcare Ltd.
10.4.1 Zydus Cadila Healthcare Ltd. Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Pregabalin
10.4.4 Pregabalin Product Introduction
10.4.5 Zydus Cadila Healthcare Ltd. Recent Development
10.5 Cipla Limited
10.5.1 Cipla Limited Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Pregabalin
10.5.4 Pregabalin Product Introduction
10.5.5 Cipla Limited Recent Development
10.6 Genesis Remedies
10.6.1 Genesis Remedies Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Pregabalin
10.6.4 Pregabalin Product Introduction
10.6.5 Genesis Remedies Recent Development
10.7 Sanofi
10.7.1 Sanofi Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Pregabalin
10.7.4 Pregabalin Product Introduction
10.7.5 Sanofi Recent Development
10.8 Medley Pharmaceuticals Limited
10.8.1 Medley Pharmaceuticals Limited Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Pregabalin
10.8.4 Pregabalin Product Introduction
10.8.5 Medley Pharmaceuticals Limited Recent Development
10.9 Genesis Biotec Inc.
10.9.1 Genesis Biotec Inc. Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Pregabalin
10.9.4 Pregabalin Product Introduction
10.9.5 Genesis Biotec Inc. Recent Development
10.10 Biomax
10.10.1 Biomax Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Pregabalin
10.10.4 Pregabalin Product Introduction
10.10.5 Biomax Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Pregabalin Sales Channels
11.2.2 Pregabalin Distributors
11.3 Pregabalin Customers
12 Market Forecast
12.1 Global Pregabalin Sales and Revenue Forecast 2019-2025
12.2 Global Pregabalin Sales Forecast by Type
12.3 Global Pregabalin Sales Forecast by Application
12.4 Pregabalin Forecast by Regions
12.4.1 Global Pregabalin Sales Forecast by Regions 2019-2025
12.4.2 Global Pregabalin Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Pregabalin Market Size Growth Rate by Type (2019-2025)
1.3.2 Epilepsy
1.3.3 Neuropathic Pain
1.3.4 Fibromyalgia
1.3.5 Generalized Anxiety Disorder
1.4 Market Segment by Application
1.4.1 Global Pregabalin Market Share by Application (2019-2025)
1.4.2 Research Institutes
1.4.3 Pharmaceutical Companies
1.4.4 Others (Hospitals and Clinics)
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pregabalin Market Size
2.1.1 Global Pregabalin Revenue 2014-2025
2.1.2 Global Pregabalin Sales 2014-2025
2.2 Pregabalin Growth Rate by Regions
2.2.1 Global Pregabalin Sales by Regions 2014-2019
2.2.2 Global Pregabalin Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Pregabalin Sales by Manufacturers
3.1.1 Pregabalin Sales by Manufacturers 2014-2019
3.1.2 Pregabalin Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Pregabalin Revenue by Manufacturers (2014-2019)
3.2.2 Pregabalin Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Pregabalin Market Concentration Ratio (CR5 and HHI)
3.3 Pregabalin Price by Manufacturers
3.4 Key Manufacturers Pregabalin Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Pregabalin Market
3.6 Key Manufacturers Pregabalin Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Epilepsy Sales and Revenue (2014-2019)
4.1.2 Neuropathic Pain Sales and Revenue (2014-2019)
4.1.3 Fibromyalgia Sales and Revenue (2014-2019)
4.1.4 Generalized Anxiety Disorder Sales and Revenue (2014-2019)
4.2 Global Pregabalin Sales Market Share by Type
4.3 Global Pregabalin Revenue Market Share by Type
4.4 Pregabalin Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Pregabalin Sales by Application
6 United States
6.1 United States Pregabalin Breakdown Data by Company
6.2 United States Pregabalin Breakdown Data by Type
6.3 United States Pregabalin Breakdown Data by Application
7 European Union
7.1 European Union Pregabalin Breakdown Data by Company
7.2 European Union Pregabalin Breakdown Data by Type
7.3 European Union Pregabalin Breakdown Data by Application
8 China
8.1 China Pregabalin Breakdown Data by Company
8.2 China Pregabalin Breakdown Data by Type
8.3 China Pregabalin Breakdown Data by Application
9 Rest of World
9.1 Rest of World Pregabalin Breakdown Data by Company
9.2 Rest of World Pregabalin Breakdown Data by Type
9.3 Rest of World Pregabalin Breakdown Data by Application
9.4 Rest of World Pregabalin Breakdown Data by Countries
9.4.1 Rest of World Pregabalin Sales by Countries
9.4.2 Rest of World Pregabalin Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Pfizer Inc.
10.1.1 Pfizer Inc. Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Pregabalin
10.1.4 Pregabalin Product Introduction
10.1.5 Pfizer Inc. Recent Development
10.2 Torrent Pharmaceuticals Ltd.
10.2.1 Torrent Pharmaceuticals Ltd. Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Pregabalin
10.2.4 Pregabalin Product Introduction
10.2.5 Torrent Pharmaceuticals Ltd. Recent Development
10.3 Lupin Limited
10.3.1 Lupin Limited Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Pregabalin
10.3.4 Pregabalin Product Introduction
10.3.5 Lupin Limited Recent Development
10.4 Zydus Cadila Healthcare Ltd.
10.4.1 Zydus Cadila Healthcare Ltd. Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Pregabalin
10.4.4 Pregabalin Product Introduction
10.4.5 Zydus Cadila Healthcare Ltd. Recent Development
10.5 Cipla Limited
10.5.1 Cipla Limited Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Pregabalin
10.5.4 Pregabalin Product Introduction
10.5.5 Cipla Limited Recent Development
10.6 Genesis Remedies
10.6.1 Genesis Remedies Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Pregabalin
10.6.4 Pregabalin Product Introduction
10.6.5 Genesis Remedies Recent Development
10.7 Sanofi
10.7.1 Sanofi Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Pregabalin
10.7.4 Pregabalin Product Introduction
10.7.5 Sanofi Recent Development
10.8 Medley Pharmaceuticals Limited
10.8.1 Medley Pharmaceuticals Limited Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Pregabalin
10.8.4 Pregabalin Product Introduction
10.8.5 Medley Pharmaceuticals Limited Recent Development
10.9 Genesis Biotec Inc.
10.9.1 Genesis Biotec Inc. Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Pregabalin
10.9.4 Pregabalin Product Introduction
10.9.5 Genesis Biotec Inc. Recent Development
10.10 Biomax
10.10.1 Biomax Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Pregabalin
10.10.4 Pregabalin Product Introduction
10.10.5 Biomax Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Pregabalin Sales Channels
11.2.2 Pregabalin Distributors
11.3 Pregabalin Customers
12 Market Forecast
12.1 Global Pregabalin Sales and Revenue Forecast 2019-2025
12.2 Global Pregabalin Sales Forecast by Type
12.3 Global Pregabalin Sales Forecast by Application
12.4 Pregabalin Forecast by Regions
12.4.1 Global Pregabalin Sales Forecast by Regions 2019-2025
12.4.2 Global Pregabalin Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
